tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PTCT Stock Latest News

Strong Buy Rating for PTC Therapeutics Driven by Sephience Launch and Strategic Growth Opportunities
RatingsStrong Buy Rating for PTC Therapeutics Driven by Sephience Launch and Strategic Growth Opportunities
4d ago
PTCT
Citizens JMP healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
Citizens JMP healthcare analysts hold an analyst/industry conference call
18d ago
BIIB
DSGN
Hold Rating on PTC Therapeutics Amid Competitive Gene Therapy Landscape and High-Risk Outlook
PremiumRatings
Hold Rating on PTC Therapeutics Amid Competitive Gene Therapy Landscape and High-Risk Outlook
25d ago
PTCT
PTC shares to see pressure on ‘compelling’ uniQure data, says Citi
PremiumThe Fly
PTC shares to see pressure on ‘compelling’ uniQure data, says Citi
25d ago
PTCT
QURE
PTC Therapeutics down 3% after uniQure Huntington’s disease data
PremiumThe Fly
PTC Therapeutics down 3% after uniQure Huntington’s disease data
25d ago
PTCT
QURE
PTC Therapeutics participates in a conference call with Truist
PremiumThe FlyPTC Therapeutics participates in a conference call with Truist
2M ago
PTCT
PTC Therapeutics Completes Study on Vatiquinone for Friedreich Ataxia in Young Children
Premium
Company Announcements
PTC Therapeutics Completes Study on Vatiquinone for Friedreich Ataxia in Young Children
2M ago
PTCT
PTC Therapeutics price target lowered to $71 from $76 at Morgan Stanley
Premium
The Fly
PTC Therapeutics price target lowered to $71 from $76 at Morgan Stanley
2M ago
PTCT
PTC Therapeutics: Buy Rating Affirmed Amid Temporary Weakness and Promising Pipeline
PremiumRatings
PTC Therapeutics: Buy Rating Affirmed Amid Temporary Weakness and Promising Pipeline
2M ago
PTCT
JPMorgan adds PTC Therapeutics to Analyst Focus List after selloff
PremiumThe Fly
JPMorgan adds PTC Therapeutics to Analyst Focus List after selloff
2M ago
PTCT
PTC Therapeutics price target lowered to $76 from $82 at BofA
PremiumThe Fly
PTC Therapeutics price target lowered to $76 from $82 at BofA
2M ago
PTCT
PTC Therapeutics price target lowered to $73 from $79 at Wells Fargo
PremiumThe Fly
PTC Therapeutics price target lowered to $73 from $79 at Wells Fargo
2M ago
PTCT
PTC Therapeutics price target lowered to $63 from $64 at Jefferies
PremiumThe FlyPTC Therapeutics price target lowered to $63 from $64 at Jefferies
2M ago
PTCT
RBC says PTC Therapeutics CRL may signal difficulty for Biohaven
Premium
The Fly
RBC says PTC Therapeutics CRL may signal difficulty for Biohaven
2M ago
BHVN
PTCT
PTC Therapeutics CRL ‘expected,’ focus moves to Sephience, says RBC Capital
Premium
The Fly
PTC Therapeutics CRL ‘expected,’ focus moves to Sephience, says RBC Capital
2M ago
PTCT
PTC Therapeutics: Buy Rating Maintained Despite Vatiquinone Setback
PremiumRatings
PTC Therapeutics: Buy Rating Maintained Despite Vatiquinone Setback
2M ago
PTCT
PTC Therapeutics price target lowered to $50 from $56 at TD Cowen
PremiumThe Fly
PTC Therapeutics price target lowered to $50 from $56 at TD Cowen
2M ago
PTCT
PTC Therapeutics: Hold Rating Amid Regulatory Setbacks and Sephience Growth Potential
PremiumRatings
PTC Therapeutics: Hold Rating Amid Regulatory Setbacks and Sephience Growth Potential
2M ago
PTCT
PTC Therapeutics Receives FDA Complete Response Letter
PremiumCompany Announcements
PTC Therapeutics Receives FDA Complete Response Letter
2M ago
8K
PTCT
PTC Therapeutics receives Complete Response Letter for vatiquinone NDA
PremiumThe FlyPTC Therapeutics receives Complete Response Letter for vatiquinone NDA
2M ago
PTCT
PTC Therapeutics’ Earnings Call Highlights Sephience Success
Premium
Company Announcements
PTC Therapeutics’ Earnings Call Highlights Sephience Success
2M ago
PTCT
PTC Therapeutics price target lowered to $70 from $72 at Baird
Premium
The Fly
PTC Therapeutics price target lowered to $70 from $72 at Baird
2M ago
PTCT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >